Dr. Benza is currently Network Director of Pulmonary Hypertension at Mount Sinai Icahn School of Medicine, New York City, Principal Investigator of the Phase II study of CS1, and member of Cereno’s Scientific Advisory Board. He has extensive clinical trial experience with involvement in just over 60 different clinical trials. Dr. Benza has also been involved in around 325 publications and written 6 books of which 3 are focused on pulmonary hypertension.